Cefaclor Chinese market analysis of the status quo and prospects

Author:ANROSOFT_market survey report Company,market survey report services.( http://anrosoft.com )

Optimistic about the hospital administration, preparation market steadily

In February 1994, cefaclor in the first successful development of our country, from Shandong Zibo pharmaceutical Suntec listed first, called the new merchandise daro. Subsequent years, because of the same optimistic about market prospects cefaclor, cefaclor domestic agents will soon set off a wave of development.

Cefaclor preparation in 2006 production reached 45. Major agents manufacturing enterprises in Shandong Zibo has Suntec Pharmaceuticals, Harbin Pharmaceutical reputation value, Hainan trefoil pharmaceutical, Guanghua Guangzhou Baiyunshan Pharmaceutical Company, Suzhou Third Pharmaceutical Factory, Sichuan pharmaceutical formulations company, Zhejiang Asia-Pacific drug industry, pharmaceutical and other Norton. Among them, the granules (dry suspension, dry syrup) has production plants in Shandong Zibo Xinda pharmaceutical, pharmaceutical gifted Shanghai, Suzhou in the pharmaceutical industry of the company, the Guangzhou Baiyun Mountain, Shantou pharmaceutical plant, such as stone; release chip manufacturing plant in Zibo, Shandong has Suntec Pharmaceuticals, Zhejiang Pharmaceuticals LP, etc., Culture and Sport.

In the hospital market, cefaclor capsules, granules have been incorporated into domestic first countries to the basic medical insurance and industrial injury insurance agent directory, directory health insurance in 2004 will be amended into the sustained-release tablets, thereby promoting the cefaclor in 2007 variety of antibiotic drugs in the market growth rate of hospital up to 35% of the market growth rate of varieties of antibiotics into the top 10.

At present, the clinical use of cefaclor in the main there is 250mg and 125mg capsules of these two specifications granules. China Chemical Pharmaceutical Industry Association statistics show that the first half of 2008, specifications for cefaclor 250mg capsules of the national total of 51,980,400, granules BAG output up to 54,664,200.

Capsule production mainly concentrated in the top three companies, namely, Shandong Zibo Xinda Pharmaceutical, Shanghai and Suzhou third of modern pharmaceuticals, the market concentration for 43.7%. Granule production mainly concentrated in Shandong Zibo Xinda pharmaceutical and Guangzhou Baiyun Mountain, the two companies account for the production of granules near 77% of the total output, up to one of the new drug, a share of over 50%.

It is understood that in 2006, the new LP of the pharmaceutical and Zhejiang, Culture and Sport has developed specifications for a new sustained-release tablets of the 375mg dosage form, one of the new production of pharmaceuticals has been achieved during the first half of this year 2,420,000.

Bright future

– Cefaclor into the balance period of the market as a whole. First half of this year, the former top 10 manufacturers ranked in 2006 are basically the same situation. The top ten manufacturing enterprises, in addition to Eli Lilly Suzhou Greek inscriptions of pharmaceutical workers, as well as the new new daro larger market share, the position of the enterprise later this year, the basic production last year.

– Cefaclor product into two camps: first, as the original drug research workers of the Greek inscription, which is a separate pricing, the current capsule (0.25g * 12) the retail price of 99 RMB / box, dry suspension (0.125g * 6 bags) for the 33.9 / box. As listed earlier, the key species in the major city hospital established.

The other products are. After several price reductions, the price of domestic cefaclor: capsule / tablet (0.25g * 12) 50.5 yuan / box, granules (0.125g * 6 bags) 16.5 RMB / box, 0.375g * release tablets 6 51 yuan / box. Overall, the domestic market more keenly cefaclor, in addition to pushing between domestic enterprises, the joint venture also faces competition for the same Units.

– Because of its advantages, such as oral Convenience, cefaclor the overall market will continue to expand scale, particularly in the field of children’s use a very bright future. According to the National Chinese Medicine Economic Information Net of monitoring, from 2005 to 2007, Beijing, Guangzhou, Tianjin, Hangzhou, more than 60 samples of cephalosporin antibiotics in the pediatric hospital of prescription increased significantly, including cefaclor, cefuroxime, cefixime, such as the largest growth in four species. These products are used in respiratory tract infections, followed by urinary tract infections.

Quinolones because of the existence of cartilage toxicity and liver toxicity, are prohibited from the following applies to 18-year-old patients, penicillins and macrolides, respectively, because of gastrointestinal problems and skin test stimulus also limits the problem in pediatrics, and the first Crowe cephalosporin antibiotics, such as spore of bacteria have a good high efficacy and safety of its prescription volume in the pediatric market gradually expanding.

It can be anticipated that a number of convenient and cost-effective use of oral antibiotics will be more and more medical staff and patients. Cefaclor twice the price adjustment, the price can be acceptable for most patients, but this product after many years of clinical applications are already quite mature. These conditions determine the prospects of the product market, there are more room for growth.

Related analysis market survey Report >>

• Global demand for solar-grade polysilicon investigate prediction and analysis
• Domestic powder coatings market research analysis
• Countries in the development of alternatives to plastic bags Investigation and Analysis
• Polysilicon industry market research analysis
• China Alumina Industry Review and Analysis
• Market research analysis of ceramic fiber
• plastic pipe industry, prospects for the development of analysis
• New type of gypsum board market analysis and investigate the prospects for prediction
• Japanese circuit board investigate the development of the market analysis
• Solar power, LED industry growth good
• Top Ten in 2008 predicted that the semiconductor industry
• Voice of Chinese electricity industry trends and market research analysis
• Development Trend of China’s timber industry and market research analysis
• China’s polysilicon industry market research analysis of the future
• The advantages and disadvantages of glass curtain wall

Contact us,I’m
Online!